Emma Reeve, Director at PTC THERAPEUTICS, INC. (PTCT), sold 10,000 shares at $79.50 ($795K) on 2025-11-21, disclosed to the SEC on 2025-11-25.
Scheduled sale ($795k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PTCT | SELL | 2025-11-14 | $1.1M | — | Filing → |
| PTCT | SELL | 2025-10-31 | $1.1M | — | Filing → |
| PTCT | SELL | 2025-10-07 | $3.4M | — | Filing → |